Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRevelation Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$20.64 | -$20.64 | -$20.64 |
| Q2 2025 | 1 | -$2.76 | -$2.76 | -$2.76 |
| Q3 2025 | 1 | -$1.70 | -$1.70 | -$1.70 |
| Q4 2025 | 1 | -$0.96 | -$0.96 | -$0.96 |
Revelation Biosciences, Inc. Earnings Date And Information
Revelation Biosciences, Inc. last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.72112 earnings per share for the quarter, topping analysts' consensus estimates of $-1.695 by $0.97388. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Revelation Biosciences, Inc. has generated $-88 earnings per share over the last year ($-87.68 diluted earnings per share) and currently has a price-to-earnings ratio of -0.25. Revelation Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 7th, 2025 based on prior year's report dates.
Revelation Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | -$1.70 | -$1.77 | -0.08 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$2.76 | -$7.01 | -4.25 | $0 | $0 |
| 05/08/2025 | Q1 2025 | -$20.64 | -$2.11 | 18.53 | $0 | $0 |
| 03/06/2025 | Q4 2024 | N/A | -$4.98 | N/A | N/A | $0 |
| 11/08/2024 | Q3 2024 | N/A | -$13.38 | N/A | N/A | $0 |
| 08/09/2024 | Q2 2024 | N/A | -$82.09 | N/A | N/A | $0 |
| 05/10/2024 | Q1 2024 | N/A | -$39.37 | N/A | N/A | $0 |
| 03/22/2024 | Q4 2023 | N/A | -$133.24 | N/A | N/A | $0 |
| 11/09/2023 | Q3 2023 | N/A | -$200.34 | N/A | N/A | $0 |
| 08/11/2023 | Q2 2023 | N/A | -$119.60 | N/A | N/A | $0 |
| 05/22/2023 | Q1 2023 | N/A | $1,337.32 | N/A | N/A | $0 |
| 03/30/2023 | Q4 2022 | N/A | -$848.74 | N/A | N/A | $0 |
| 11/10/2022 | Q3 2022 | N/A | -$934.08 | N/A | N/A | $0 |
| 08/15/2022 | Q2 2022 | N/A | -$2,043.55 | N/A | N/A | $0 |
| 05/13/2022 | Q1 2022 | N/A | -$7,826.95 | N/A | N/A | $0 |
| 04/15/2022 | Q4 2021 | N/A | -$6,569.81 | N/A | N/A | $0 |
| 10/29/2021 | Q3 2021 | N/A | -$8,129.35 | N/A | N/A | $0 |
| 08/23/2021 | Q2 2021 | N/A | -$6,594.34 | N/A | N/A | $0 |
| 06/22/2021 | Q1 2021 | N/A | -$6,977.04 | N/A | N/A | $0 |
| 03/31/2021 | Q4 2020 | N/A | -$2,965.37 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Revelation Biosciences, Inc. Earnings: FAQ's
Revelation Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 7th, 2025 based offlast year's report dates.
In the previous quarter, Revelation Biosciences, Inc. (:REVBW) reported $-0.72112 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.695 by $0.97388.
The conference call for Revelation Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Revelation Biosciences, Inc.'s latest earnings report can be read online.
Revelation Biosciences, Inc. (:REVBW) has a recorded net income of $-15,038,536.Revelation Biosciences, Inc. has generated $-87.68 earnings per share over the last four quarters.
Revelation Biosciences, Inc. (:REVBW) has a price-to-earnings ratio of -0.25 and price/earnings-to-growth ratio is -0.01.